The use of metformin has been associated with improved survival in patients with different types of cancers, including those with GC after gastrectomy [16], those with diabetes who were diagnosed with GC in a Swedish population-based cohort study [17], those with HER2 positive BC in a population study [18], and laboratory studies [19,20,21]. Here, ERBB2 is linked to gastric cancer.